Tag Index  /  Showing 1 - 3 of 3 results for “Floyd Romesberg”

Bio & Life Sciences Techonomy Events

Talking About Biology’s Grass Roots Revolution

“As a reporter who’s covered both biotech and what the rest of the world calls just plain ‘tech,’ I can tell you those stories about biology can be tougher to tell,” said WIRED senior writer Marcus Wohlsen during a session, entitled "The Next Revolution Will Be Biologized," that he moderated at Techonomy 2014 in Half Moon Bay last week. Wholsen shared the stage with a panel of the sector’s thought leaders: attorney and consultant Nancy Kelley; chemical biologist Floyd Romesberg of The Scripps Research Institute; synthetic biology pioneer Drew Endy of Stanford University; and Brian Frezza, founder of “biotech lab for hire” Emerald Therapeutics.   More

Bio & Life Sciences Healthcare

Scripps Bio-Chemist Romesberg: Proteins and Enzymes Could Transform Industry and Medicine

How can a better understanding of evolution help us improve human health? Renowned bio-chemist Floyd Romesberg of the Scripps Research Institute can think of a few ways. For one, cancer cells evolve and grow by “out-competing” neighboring cells, a process Romesberg calls “evolution just run faster than we’re used to.” We spoke to Romesberg at our recent Techonomy Bio event in Mountain View, Calif. He says understanding how our genomes have evolved will give us insights into the genetic diseases we get, and help us treat them. But to fully comprehend the evolutionary process, we have to look at proteins. “Understanding how proteins function is absolutely essential to our understanding of life,” said Romesberg.   More

Bio & Life Sciences Techonomy Events

What We Learned at Techonomy Bio

Techonomy's offices on Manhattan's West 22d Street have been buzzing ever since our half-day Techonomy Bio conference on June 17. We got an overwhelmingly positive reception for a meeting that brought leading researchers and experts in the life sciences together with IT and Internet thinkers and business generalists. Drew Endy, a Stanford professor who is one of the world's leaders in synthetic biology, on stage called the event "awesome" and said he had never seen such a collection of people in one place. "People in other sectors of technology simply don’t know very much about biology and biology’s economic impact," he said.   More